Applied Microbiology
Applied Microbiology is a set of practices that use living cells or component cells such as enzymes to generate industrial products & processes. It is a key enabling technology to realize a bio-economy that uses biological resources as an input to industrial processes, and bio-based processes to help industries become more environmentally sustainable.
Microbial productions have occupied a significant role in various areas of fermentation industry, food and beverage industry, biotechnology research, detergent industry. Microbial productions have a pivotal responsibility in industrial biotechnology which involves the use of microorganisms and enzymes to produce biobased products in sectors like chemicals, food & feed, paper, textiles and bioenergy. Microbial products include antibiotics, enzymes, vitamins, amino acids. Antibiotics are substances derived by some bacteria or fungi that can either inhibit the growth or kill other microorganisms. Antibiotics are produced industrially by fermentation where the source microorganism is grown in containers of size 100,000–150,000 litters or more in the presence of liquid growth medium.
Scope and Importance: Microalgae as a biofactory offer a promising approach towards the production of omega-3 fatty acids such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). These fatty acids provide significant health benefits and their consumption has increased as dietary supplements. Microalgal biotechnology explores the potential applications of autotrophic microalgae as aquaculture feed and in the development of biofuel crops. Microalgae can also be used as the production platforms for the development of omega- 3 fatty acids. Studies have reported that techniques like metabolic engineering and selective breeding can be applied successfully to produce large amounts of omega-3 fatty acids in microalgae.
Microbial cells, either bacteria or yeast are used as hosts to produce recombinant pharmaceuticals. Food and Drug Administration (FDA) and the European Medicines Agency (EMEA) have represented that the microbial cells represent convenient and powerful tools for recombinant protein production. Biofactory refers to any system that can produce useful amounts of biologically-active compounds such as recombinant proteins, therapeutics. Hosts such as bacteria, yeasts, mammalian and insect cells, transgenic plants and animals can be exploited for the large-scale production of diagnostic and therapeutic proteins. Molecular farming which is a keystone tool of plant biotechnology focuses on the exploitation of plants of agronomic relevance as biofactories for large-scale production of biomolecules. The whole plant or plant cell culture have been used for the production of biopharmaceuticals like cytokines, blood proteins, milk proteins, hormones, antibodies, metabolic enzymes, antigens and vaccines and many more biological molecules used in animal and human health care.
Related Conference of Applied Microbiology
10th International Congress on Trauma, Critical Care and Emergency Medicine
19th International Conference on Virology, Emerging Diseases & vaccines
9th International Conference on Molecular Medicine and Diagnostics
8th International Conference on Microbiome, Probiotics & Gut Nutrition
7th International Conference on Antimicrobial and Antibacterial Agents
7th International Conference on Clinical Microbiology, Virology and Infectious Diseases
Applied Microbiology Conference Speakers
Recommended Sessions
- Antimicrobials
- Applied Microbiology
- Biogeochemical cycles
- Carbon cycle and Bioenergy
- Effects of climate change on microbial community
- Evolution of microbial lives
- Food microbiology
- Hazardous waste management
- Host-pathogen interactions
- Metagenomics
- Microbial Biofilms
- Microbial eukaryotes
- Microbial interactions
- Plant and Agricultural Microbiology
- Pollution control and Global Warming
- Public Health Microbiology
- Recycling
- Soil Microbiology
Related Journals
Are you interested in
- 16S sequencing & Analysis - Microbiome 2024 (UK)
- Agriculture Microbiology - Beneficial Microbes 2024 (Ireland)
- Animals in a bacterial world, a new imperative for the life sciences - Microbiome 2024 (UK)
- Antimicrobial Use in Veterinary Medicine - Antimicrobial Congress 2024 (Czech Republic)
- Antimicrobials - Antimicrobial Congress 2024 (Czech Republic)
- Antiviral Therapies and Drug Development - Antimicrobial Congress 2024 (Czech Republic)
- Arbuscular Mycorrhizal Fungi [AMF] - Microbiome 2024 (UK)
- Beneficial Microbes in the environment - Beneficial Microbes 2024 (Ireland)
- Benefits Of Bio stimulants - Microbiome 2024 (UK)
- Bioinformatics for Microbiome - Microbiome 2024 (UK)
- Biological Need of Trauma - TRAUMA 2024 (Netherlands)
- Biostimulants and Biocontrol strategies - Microbiome 2024 (UK)
- Blunt Trauma - TRAUMA 2024 (Netherlands)
- Clinical and Neuro Virology - Virology-2024 (Canada)
- Combination Therapy for Antimicrobial Resistance - Antimicrobial Congress 2024 (Czech Republic)
- Corona Virus - Virology-2024 (Canada)
- Critical Care in Trauma - TRAUMA 2024 (Netherlands)
- Delirium in Critical Care - TRAUMA 2024 (Netherlands)
- Drug-Resistant Bacteria: Challenges and Solutions - Antimicrobial Congress 2024 (Czech Republic)
- Ecology and Evolution of Microbe-Host Interactions - Beneficial Microbes 2024 (Ireland)
- Elderly Trauma and Critical Care - TRAUMA 2024 (Netherlands)
- Engineering Beneficial Microbes - Beneficial Microbes 2024 (Ireland)
- Evolution in Emergency Medicine Practices - TRAUMA 2024 (Netherlands)
- General Virology - Virology-2024 (Canada)
- Gut Micro biota - Microbiome 2024 (UK)
- Harnessing phyto Microbiome signaling for Microbiome engineering - Microbiome 2024 (UK)
- Harnessing phyto Microbiome signaling for Microbiome engineering - Microbiome 2024 (UK)
- HIV/AIDS and Sexually Transmitted Infections - Virology-2024 (Canada)
- Horticulture Hydroponics - Microbiome 2024 (UK)
- Host-Microbe Biology (HMB) - Microbiome 2024 (UK)
- Human Micro biota - Microbiome 2024 (UK)
- Immunization and Immunotherapeutics - Virology-2024 (Canada)
- Immunobiotics - Beneficial Microbes 2024 (Ireland)
- Influenza and other Respiratory Diseases - Virology-2024 (Canada)
- Intensive Care in Trauma - TRAUMA 2024 (Netherlands)
- Interplay between diet, gut micro biota, epigenetic events, and colorectal cancer - Microbiome 2024 (UK)
- Marine Microbiology - Beneficial Microbes 2024 (Ireland)
- Mechanisms of Antibiotic Resistance - Antimicrobial Congress 2024 (Czech Republic)
- Micro biota in early life shapes the immune system - Microbiome 2024 (UK)
- Microbial Infections - Virology-2024 (Canada)
- Microbiome - Beneficial Microbes 2024 (Ireland)
- Microbiome - Microbiome 2024 (UK)
- Microbiome as a human organ - Microbiome 2024 (UK)
- Microbiome: Science comes to life - Microbiome 2024 (UK)
- Modulation of Micro biota - Microbiome 2024 (UK)
- Nanotechnology in Antimicrobial Drug Delivery - Antimicrobial Congress 2024 (Czech Republic)
- New and Endogenous Retroviruses - Virology-2024 (Canada)
- New Technology in Trauma - TRAUMA 2024 (Netherlands)
- Novel Antibiotics and Antimicrobial Agents - Antimicrobial Congress 2024 (Czech Republic)
- Novel Antiviral Therapies - Virology-2024 (Canada)
- Novel Vaccine Delivery Methods - Virology-2024 (Canada)
- Obstetric Trauma - TRAUMA 2024 (Netherlands)
- Paediatric Trauma - TRAUMA 2024 (Netherlands)
- Pathogenic Microbes in Immunology and Microbiology - Beneficial Microbes 2024 (Ireland)
- Pathogenic Microbes in Medicine and Dentistry - Beneficial Microbes 2024 (Ireland)
- Pediatric Microbiome [Vaginal Delivery Versus C-Section] - Microbiome 2024 (UK)
- Pharmacogenomics - Microbiome 2024 (UK)
- Pharmacokinetics and Pharmacodynamics of Antimicrobials - Antimicrobial Congress 2024 (Czech Republic)
- Plant Beneficial Microbes - Microbiome 2024 (UK)
- Plant Conditioners [Biostimulants] - Microbiome 2024 (UK)
- Prebiotics and Probiotics - Microbiome 2024 (UK)
- Probiotics & Prebiotics - Beneficial Microbes 2024 (Ireland)
- Psychological Trauma - TRAUMA 2024 (Netherlands)
- Role of microbial communities in the pathogenesis of periodontal diseases and caries (Oral Microbiome) - Microbiome 2024 (UK)
- Signaling in the phytoMicrobiome - Microbiome 2024 (UK)
- Skincare products with probiotics worth the hype - Microbiome 2024 (UK)
- Soil biological management - Beneficial Microbes 2024 (Ireland)
- Strategies for Fungal Infections - Antimicrobial Congress 2024 (Czech Republic)
- Structural and Molecular virology - Virology-2024 (Canada)
- The Dynamic Microbiome - Microbiome 2024 (UK)
- The globalization of cannabis cultivation- A Growing Challenge - Microbiome 2024 (UK)
- The Microbiome as a Therapeutic Target for Metabolic Diseases - Microbiome 2024 (UK)
- The role of the Microbiome in cancer development and therapy - Microbiome 2024 (UK)
- The Skin Microbiome - Microbiome 2024 (UK)
- Transmission of Viruses - Virology-2024 (Canada)
- Transplant-Associated Viral Infections - Virology-2024 (Canada)
- Trauma & Critical Care Nursing - TRAUMA 2024 (Netherlands)
- Trauma Emergency Medicine - TRAUMA 2024 (Netherlands)
- Trauma in Nursing & Midwifery - TRAUMA 2024 (Netherlands)
- Trauma Therapy - TRAUMA 2024 (Netherlands)
- Trauma-An International Perspective - TRAUMA 2024 (Netherlands)
- Trauma-Mass Casualties Incidents - TRAUMA 2024 (Netherlands)
- Vaccines against Emerging Diseases (Ebola/Zika/Dengue/Chik) - Virology-2024 (Canada)
- Vaccines and Immunotherapies - Antimicrobial Congress 2024 (Czech Republic)
- Vaccines and the Microbiome - Virology-2024 (Canada)
- Veterinary virology - Virology-2024 (Canada)
- Viral Genetics, Evolution and Dynamics - Virology-2024 (Canada)
- Viral Immunology and Immunopathology - Virology-2024 (Canada)
- Viral Oncology - Virology-2024 (Canada)
- Viral Pathogenesis - Virology-2024 (Canada)